A Study of EXG102-031 in Participants With wAMD

Clinical trial NCT06183814 · UNKNOWN

Trial details

NCT number: NCT06183814
Sponsor: Guangzhou Jiayin Biotech Ltd
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neovascular Age-related Macular Degeneration

Start date: 2023-10-12
Primary completion: 2025-12-31
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.